Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and older

被引：0
作者：
Min Hwan Kim
Gun Min Kim
Jee Hung Kim
Jee Ye Kim
Hyung Seok Park
Seho Park
Young Up Cho
Byeong Woo Park
Seung Il Kim
Joohyuk Sohn
机构：
[1] Yonsei University College of Medicine,Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center
[2] Gangnam Severance Hospital,Division of Medical Oncology, Department of Internal Medicine
[3] Yonsei University College of Medicine,Division of Breast Surgery, Department of Surgery, Yonsei Cancer Center
[4] Yonsei University College of Medicine,undefined
来源：
Breast Cancer Research and Treatment | 2020年 / 179卷
关键词：
Intermediate HER2; Age; Prognosis; Metastatic breast cancer; Early breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：687 / 697
页数：10
相关论文
共 50 条
  • [41] FOXA1 Expression Significantly Predict Response to Chemotherapy in Estrogen Receptor-Positive Breast Cancer Patients
    Xu, Chenpu
    Wei, Qun
    Guo, Jufeng
    Zhou, Ji Chun
    Mei, Jin
    Jiang, Zhi Nong
    Shen, Jian Guo
    Wang, Lin Bo
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (06) : 2034 - 2039
  • [42] Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer
    Akiko Ogiya
    Kieko Yamazaki
    Rie Horii
    Tadahiko Shien
    Yoshiya Horimoto
    Norikazu Masuda
    Touko Inao
    Mitsuchika Hosoda
    Naoko Ishida
    Tomofumi Osako
    Masato Takahashi
    Yumi Endo
    Yuichiro Miyoshi
    Hiroyuki Yasojima
    Nobumoto Tomioka
    Hiroko Yamashita
    Breast Cancer, 2017, 24 : 473 - 482
  • [43] Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer
    Ogiya, Akiko
    Yamazaki, Kieko
    Horii, Rie
    Shien, Tadahiko
    Horimoto, Yoshiya
    Masuda, Norikazu
    Inao, Touko
    Hosoda, Mitsuchika
    Ishida, Naoko
    Osako, Tomofumi
    Takahashi, Masato
    Endo, Yumi
    Miyoshi, Yuichiro
    Yasojima, Hiroyuki
    Tomioka, Nobumoto
    Yamashita, Hiroko
    BREAST CANCER, 2017, 24 (03) : 473 - 482
  • [44] SLC35A2 expression is associated with HER2 expression in breast cancer
    Wang, Yiran
    Peng, Xiaobo
    Wu, Meihong
    Wang, Bin
    Chen, Tianran
    Zhan, Xianbao
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [45] Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer
    Zhike Chen
    Yate-Ching Yuan
    Yuanzhong Wang
    Zheng Liu
    Hei Jason Chan
    Shiuan Chen
    Breast Cancer Research and Treatment, 2015, 152 : 29 - 39
  • [46] EarlyR: A Robust Gene Expression Signature for Predicting Outcomes of Estrogen Receptor-Positive Breast Cancer
    Buechler, Steven A.
    Gokmen-Polat, Yesim
    Badve, Sunil S.
    CLINICAL BREAST CANCER, 2019, 19 (01) : 17 - +
  • [47] Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer
    Chen, Zhike
    Yuan, Yate-Ching
    Wang, Yuanzhong
    Liu, Zheng
    Chan, Hei Jason
    Chen, Shiuan
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 152 (01) : 29 - 39
  • [48] Effect of CD44st and HER2 expression on the postoperative prognosis of breast cancer patients
    Chen, Dan Dan
    Ji, Jun An
    Cuiyan, Hai
    Huan, Guan Hong G.
    Fang, Xin Jian
    ONCOTARGETS AND THERAPY, 2019, 12 : 577 - 585
  • [49] The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 −) advanced/metastatic breast cancer
    Aditya Bardia
    Ingrid Mayer
    Eric Winer
    Hannah M. Linden
    Cynthia X. Ma
    Barbara A. Parker
    Meritxell Bellet
    Carlos L. Arteaga
    Sravanthi Cheeti
    Mary Gates
    Ching-Wei Chang
    Jill Fredrickson
    Jill M. Spoerke
    Heather M. Moore
    Jennifer Giltnane
    Lori S. Friedman
    Edna Chow Maneval
    Iris Chan
    Komal Jhaveri
    Breast Cancer Research and Treatment, 2023, 197 : 319 - 331
  • [50] Elevated ASCL2 expression in breast cancer is associated with the poor prognosis of patients
    Xu, Hui
    Zhao, Xi-Long
    Liu, Xue
    Hu, Xu-Gang
    Fu, Wen-Juan
    Li, Qian
    Wang, Yan
    Ping, Yi-Fang
    Zhang, Xia
    Bian, Xiu-Wu
    Yao, Xiao-Hong
    AMERICAN JOURNAL OF CANCER RESEARCH, 2017, 7 (04): : 955 - 961
12345